Overall, our tumor tissue results are largely consistent with the findings of Kim et al.,33 who reported elevated levels of IL‐2, IL‐12A, and IFNG in the plasma samples of patients with NAM. The gene discussed is IL12A; the disease is Bailey-Bloch congenital myopathy.